Universe Pharmaceuticals (UPC) Equity Average (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Equity Average for 5 consecutive years, with $50.8 billion as the latest value for Q3 2025.
- Quarterly Equity Average rose 38.33% to $50.8 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $50.8 billion through Sep 2025, up 38.33% year-over-year, with the annual reading at $50.8 billion for FY2025, 38.33% up from the prior year.
- Equity Average hit $50.8 billion in Q3 2025 for Universe Pharmaceuticals, up from $36.7 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $50.8 billion in Q3 2025 to a low of $33.9 million in Q3 2021.
- Historically, Equity Average has averaged $27.4 billion across 5 years, with a median of $31.7 billion in 2023.
- Biggest five-year swings in Equity Average: skyrocketed 52082.92% in 2022 and later increased 16.07% in 2024.
- Year by year, Equity Average stood at $33.9 million in 2021, then surged by 52082.92% to $17.7 billion in 2022, then soared by 78.93% to $31.7 billion in 2023, then rose by 16.07% to $36.7 billion in 2024, then soared by 38.33% to $50.8 billion in 2025.
- Business Quant data shows Equity Average for UPC at $50.8 billion in Q3 2025, $36.7 billion in Q3 2024, and $31.7 billion in Q3 2023.